Oxalic Acid

Oxalic Acid

SCHEMBL1333025

O=C(O)C(=O)O.O=CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL11647373 0.95 CA1 (0.46)
Oxalic Acid SCHEMBL17967714 0.91 CA1 (0.42)
Oxalic Acid SCHEMBL11570543 0.88 CA1 (0.39)
Oxalic Acid SCHEMBL9062722 0.88 TSHR (0.38)
Oxalic Acid SCHEMBL17967716 0.84 CA4 (0.38)
Bicarbonate SCHEMBL5154473 0.84
Bicarbonate SCHEMBL10451074 0.84 CA1 (0.56)
Formic Acid SCHEMBL741409 0.84
Bicarbonate SCHEMBL7118766 0.80
Bicarbonate SCHEMBL11728075 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113454229-A Methods and compositions for treating hyperoxaluria 诺沃梅生物技术股份有限公司 2021-09-28 CN claimed
EP-0941053-A1 SKIN LIGHTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-15 EP claimed
WO-1998019665-A1 SKIN LIGHTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-14 WO claimed
EP-0410946-B1 Decomposition of detrimental substances TANAKA PRECIOUS METAL IND (JP) 1994-05-04 EP claimed
EP-0164286-B1 A PROCESS FOR THE PRODUCTION OF ADDITIVES FOR LUBRICANTS WITH DETERGENT AND DISPERSANT PROPERTIES BASED ON NON-FOAMING ALKYLARYLSULFONATES OF ALKALINE-EARTH METALS OROGIL (FR) 1989-08-02 EP claimed
WO-2024129974-A1 RECOMBINANT BACTERIA FOR USE IN THE TREATMENT OF DISORDERS IN WHICH OXALATE IS DETRIMENTAL SYNLOGIC OPERATING COMPANY, INC. (US) 2024-06-20 WO disclosed
US-20240197843-A1 BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL SYNLOGIC OPERATING COMPANY, INC. (US) 2024-06-20 US disclosed
CN-118139983-A Orthogonal metabolism framework for one-carbon utilization 摩珈生物科技有限公司 2024-06-04 CN disclosed
EP-4313089-A1 BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL Synlogic Operating Company, Inc. (US) 2024-02-07 EP disclosed
CN-117083068-A Bacteria engineered to treat conditions in which oxalate is detrimental 同生运营公司 2023-11-17 CN disclosed
CN-116670269-A Engineered microorganisms 同生运营公司 2023-08-29 CN disclosed
CN-116348608-A Synthetic growth based on one-carbon substrates 南佛罗里达大学 2023-06-27 CN disclosed
US-7648928-B2 Composition and method for enhancing stain resistance and product of enhanced stain resistance therefrom TRICHROMATIC CARPET INC. (CA) 2010-01-19 US disclosed
US-20090202729-A1 Composition and method for enhancing stain resistance and product of enhanced stain resistance therefrom TRICHROMATIC CARPET INC. 2009-08-13 US disclosed
US-20080124992-A1 Composition and method for enhancing stain resistance and product of enhanced stain resistance therefrom TRICHROMATIC CARPET INC. 2008-05-29 US disclosed
EP-0410946-B1 Decomposition of detrimental substances TANAKA PRECIOUS METAL IND (JP) 1994-05-04 EP disclosed
EP-0427771-A1 MACROLACTAM ANTIMICROBIAL COMPOUNDS SCHERING CORPORATION (US) 1991-05-22 EP disclosed
EP-0410946-A1 Decomposition of detrimental substances TANAKA KIKINZOKU KOGYO K.K. (JP) 1991-01-30 EP disclosed
EP-0357226-A1 Macrolactam antimicrobial compounds SCHERING CORPORATION (US) 1990-03-07 EP disclosed
WO-1990001491-A1 MACROLACTAM ANTIMICROBIAL COMPOUNDS SCHERING CORPORATION (US) 1990-02-22 WO disclosed